RESEARCH ARTICLE Prevalence of peripheral n a

Full list of author information is available at the end of the articleBackground HIV/AIDS continues to cause high mortality and mor-bidity in many sub – Saharan African countries [1]. The introduction of antiretroviral combination therapy has dramatically reduced the mortality rate of people living with HIV [2,3]. However, with substantially expanded life expectancy and the long-term use of antiretroviral therapy, complications such as peripheral neuropathy (PN) are the most prevalent neurological manifestations now seen in HIV/AIDS [4]. Peripheral neuropathy com-monly affects people’s daily function and quality of life (QoL) among populations with HIV infection [5]. In addition, the PN is likely enhanced by various demo-graphic and health status characteristics, among the PLHIV [6]. Existing data on prevalence of peripheral neuropathy is poor and there is no known data as to how peripheral neuropathy is associated with differen